Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 April 2023 | Story Kekeletso Takang | Photo Charl Devenish
Dr Carla Serfontein
UFS School of Accountancy Senior Lecturer, Dr Carla Serfontein, obtained her PhD in Management Accounting.

How many chartered accountants do you know who are also PhD holders? Dr Carla Serfontein, Senior Lecturer in Management Accounting in the University of the Free State (UFS) School of Accountancy, challenged the status quo. Dr Serfontein walked across the Callie Human stage during the morning graduation session on Wednesday 19 April 2023.

Obtaining a PhD is a milestone in the career of any academic, attesting not only to being a subject matter expert with proven credibility, but also to many hours of personal sacrifice and commitment to their discipline. Individuals who hold a PhD while also being a chartered accountant (SA) are relatively scarce, but this is an ideal combination for South African accountancy academics – as they have stature both from a professional and academic perspective. The UFS School of Accountancy is fortunate to have three such individuals, including Dr Serfontein, who was recently awarded her PhD in Management Accounting.

Dr Serfontein says obtaining her PhD in her lecturing field has expanded her knowledge in the subject area. “The UFS supported me by giving me the opportunity to be supervised by two truly outstanding academics, Prof Van Aardt Smit and Dr Cornelie Crous. That, to me, was an invaluable contribution, not only in obtaining this qualification but also in the growth that I experienced on this journey.”

Prof Frans Prinsloo, Director of the School of Accountancy, says he is proud of Dr Serfontein’s achievement. “With her thesis, Cost Efficiency at South African Universities, she highlights the flaws of conventional budgeting techniques in ensuring cost efficiencies and maximising input-output relationships at South African universities.  This is indeed a ground-breaking study and holds significant implications for how universities should be managed from a financial perspective. We are proud to have individuals of Dr Serfontein’s stature in the School of Accountancy.”

News Archive

Link between champagne bubbles and the UFS?
2012-11-16

Prof. Lodewyk Kock with an example of a front page of the publication FEMS Yeast Research, as adapted by F. Belliard, FEMS Central Office.
Photo: Leatitia Pienaar
15 November 2012

What is the link between the bubbles in champagne and breakthrough research being done at the Mayo Clinic in America? Nano research being done at our university.

Prof. Lodewyk Kock of Biotechnology says a human being consists of millions of minute cells that are invisible to the eye. The nano technology team at the UFS have developed a technique that allows researchers to look into such a cell, as well as other microorganisms. In this way, they can get an idea of what the cell’s “insides” look like.

The UFS team – consisting of Profs. Kock, Hendrik Swart (Physics), Pieter van Wyk (Centre for Microscopy), as well as Dr Chantel Swart (Biotechnology), Dr Carlien Pohl (Biotechnology) and Liza Coetsee (Physics) – were amazed to see that the inside of cells consist of a maze of small tunnels or blisters. Each tunnel is about 100 and more nanometres in diameter – about one ten thousandth of a millimetre – that weaves through the cells in a maze.

It was also found that these tunnels are the “lungs” of the cells. Academics doing research on yeast have had to sit up and take notice of the research being done at the UFS – to the extent that these “lungs” will appear on the front page of the highly acclaimed FEMS Yeast Research for all of 2013.

The Mayo Clinic, in particular, now wants to work with the UFS to study cancer cells in more detail in order to fight this disease, says Prof. Kock. The National Cancer Institute of America has also shown interest. This new nano technology for biology can assist in the study and development of nano medicine that can be used in the treatment of cancer and other life threatening diseases. Nano medicine uses nano metal participles that are up to one billionth of a metre in size.

Prof. Kock says laboratory tests indicate that nano medicine can improve the efficacy of anti-cancer medicine, which makes the treatment less toxic. “According to the Mayo Clinic team, nano particles are considered as a gold cartridge which is being fired directly at a cancer tumour. This is compared to fine shot that spreads through the body and also attacks healthy cells.”

“This accuracy implies that the chemotherapy dose can be lowered with fewer side effects. The Mayo Clinic found that one-tenth of the normal dosage is more effective against pancreas cancer in this way than the full dosage with a linkage to nano particles. According to the clinic, this nano medicine could also delay the spread of cancer,” says Prof. Kock.

The nano particles are used as messengers that convey anti-cancer treatment to cancer cells, where it then selectively kills the cancer cells. The transport and transfer of these medicines with regard to gold nano particles can be traced with the UFS’s nano technology to collect more information, especially where it works on the cell.

“With the new nano technology of the UFS, it is possible to do nano surgery on the cells by slicing the cells in nanometre thin slices while the working of the nano medicine is studied. In this way, it can be established if the nano medicine penetrates the cells or if it is only associated with the tiny tunnels,” says Prof. Kock.

And in champagne the small “lungs” are responsible for the bubbles. The same applies to beer and with this discovery a whole new reach field opens for scientists.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept